Ag-tech startup Athian secures investors for $5M funding round
Athian expects to begin beta testing for its first product this month. The company was launched last year by Greenfield-based Elanco and Indianapolis-based High Alpha Innovation.
Athian expects to begin beta testing for its first product this month. The company was launched last year by Greenfield-based Elanco and Indianapolis-based High Alpha Innovation.
Shares in the animal health care company have lost more than two-thirds of their value in the past 18 months, but Elanco says a bevy of new products in its pipeline will prove an era of strong growth is yet to come.
The Greenfield-based maker of animal medicines said fourth-quarter revenue fell due to “environmental and competitive pressure” and could continue to slip this year.
Elanco Animal Health CEO Jeff Simmons says Indianapolis faces “significant realities” it must tackle to become a destination for talent, companies and innovators.
Speaking during a luncheon hosted by the Economic Club of Indiana on Wednesday, Elanco CEO Jeff Simmons addressed downtown’s struggles with homelessness, infrastructure, talent attraction and retention, and real estate.
When the dollar is strong, a U.S.-based company that sells products overseas earns fewer dollars. On the flip side, the cost of imported goods and foreign expenses are lower.
The Greenfield-based company will lay out the design for its $100 million-plus global headquarters in Indianapolis on Thursday before a hearing examiner, who will rule on the project.
U.S. District Court Judge Sarah Evans Barker ruled the plaintiffs failed to clearly show that public statements made by Elanco’s top officials were false and misleading during a two-year period in question.
BiomEdit, one of Indiana’s newest life-science companies, said Monday it will locate its headquarters in Fishers, but hinted it could eventually move to the new $100 million Elanco Animal Health headquarters campus now under construction in Indianapolis.
Several analysts said Elanco faces a bright future, implying that the market might be overreacting to the lowered revenue and profit guidance.
CEO Jeff Simmons explains why the project is far more than simply an office building. He tells host Mason King that the goal is to create what the company calls “a post-COVID workplace destination” that attracts talent to the city and the company and gives workers more flexibility and engagement.
CEO Jeff Simmons’ goal is to make Indianapolis “an epicenter of animal health innovation.” While a bold goal, Simmons has proven he is a bold leader who prioritizes the growth of his company, as well as the community.
Elanco Animal Health Inc. on Tuesday broke ground and shared new designs for its planned $100 million-plus global headquarters at the former General Motors Stamping Plant site just west of downtown Indianapolis.
Elanco Animal Health Inc. said Thursday morning that revenue climbed 46% last year and its net loss narrowed, strengthening its financial position as it prepares to break ground this spring on a new $100 million headquarters in Indianapolis.
The startup, Athian, aims to help farmers and ranchers measure, and eventually monetize, their efforts to reduce the carbon footprint of their cattle operations.
Elanco Animal Health Inc. officials say they expect to break ground on the company’s new $100 million headquarters just west of downtown Indianapolis in early 2022 after fine-tuning plans for the project with city and state officials.
Elanco said the cuts, which include three executive vice presidents, were an effort in “streamlining and simplifying organizational structure,” and were intended to increase productivity and reduce organizational complexity.
Greenfield-based Elanco Animal Health Inc. disclosed on Monday that it received a subpoena from the U.S. Securities and Exchange Commission on July 1 related to its channel inventory and sales practices prior to mid-2020.
Shares of the Greenfield-based maker of animal feeds and vaccines dove after the firm warned that it’s facing inflationary pressures, increased logistics costs and other headwinds.
The project was given a final, and unanimous, approval by the city’s Metropolitan Development Commission—the last step necessary to allow the city to request the funds from the Indianapolis Bond Bank.